Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00363909 · ClinicalTrials.gov registry record · Phase 3
Citalopram in Treating Postmenopausal Women With Hot Flashes
A Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 3
- Development phase
- 254
- Enrollment target
NCT00363909 is a Phase 3 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 254 participants.
The verdict
NCT00363909, a Phase 3 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 254 participants
- Enrollment target
Study Summary
RATIONALE: Citalopram may help relieve hot flashes in women who had or have not had breast cancer. It is not yet known which dose of citalopram is more effective in treating hot flashes in postmenopausal women. PURPOSE: This randomized phase III trial is studying three different doses of citalopram to compare how well they work in treating postmenopausal women with hot flashes.
Interventions
- OTHER placebo
- DRUG citalopram hydrobromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2006-11 |
| Est. Completion | 2010-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00363909
The ClinicalTrials.gov registry entry for NCT00363909 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00363909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00363909 about?
NCT00363909 is a clinical study titled "Citalopram in Treating Postmenopausal Women With Hot Flashes". RATIONALE: Citalopram may help relieve hot flashes in women who had or have not had breast cancer. It is not yet known which dose of citalopram is more effective in treating hot flashes in postmenopausal women. PURPOSE: This randomized phase III trial is studying three different doses of citalopram...
What is the current status of trial NCT00363909?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 254 participants. The study started on 2006-11. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00363909?
The interventions under investigation include: placebo (OTHER), citalopram hydrobromide (DRUG).
Who is sponsoring clinical trial NCT00363909?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.